These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16626441)

  • 41. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
    Hariprasad SM; Shah GK
    Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula.
    Lee SC; Seong YS; Kim SS; Koh HJ; Kwon OW
    Ophthalmologica; 2004; 218(3):193-201. PubMed ID: 15103216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pigment epithelial changes in young women treated with photodynamic therapy and limited macular translocation for classic choroidal neovascularisation.
    Glacet-Bernard A; Coscas G; Soubrane G
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1373-6. PubMed ID: 16523298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
    Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
    Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Verteporfin photodynamic therapy of choroidal neovascularization secondary to ocular toxoplasmosis.
    Wirthlin R; Song A; Song J; Rosenfeld PJ
    Arch Ophthalmol; 2006 May; 124(5):741-3. PubMed ID: 16682600
    [No Abstract]   [Full Text] [Related]  

  • 46. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
    Sharp DM; Lai S; Markey CM
    Clin Exp Ophthalmol; 2007; 35(1):24-31. PubMed ID: 17300567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Choroidal neovascularization from a presumed subretinal nematode.
    Chen FK; Kennedy C
    Arch Ophthalmol; 2007 Sep; 125(9):1298-9. PubMed ID: 17846381
    [No Abstract]   [Full Text] [Related]  

  • 48. Photodynamic therapy using verteporfin-induced minimal change nephrotic syndrome.
    Kang SW; Kang SJ; Kim HO; Nam ES; Lee JH; Koh HJ
    Am J Ophthalmol; 2002 Dec; 134(6):907-8. PubMed ID: 12470762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy.
    Ergun E; Tittl M; Stur M
    Arch Ophthalmol; 2004 Jan; 122(1):37-41. PubMed ID: 14718292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bilateral juvenile choroidal neovascularization associated with Best's vitelliform dystrophy: observation versus photodynamic therapy.
    Viola F; Villani E; Mapelli C; Staurenghi G; Ratiglia R
    J Pediatr Ophthalmol Strabismus; 2010; 47(2):121-2. PubMed ID: 20349908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complications after photodynamic therapy.
    Schnurrbusch UE; Jochmann C; Einbock W; Wolf S
    Arch Ophthalmol; 2005 Oct; 123(10):1347-50. PubMed ID: 16219725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neovascular growth following photodynamic therapy for choroidal hemangioma and neovascular regression after intravitreous injection of triamcinolone.
    Leys AM; Silva R; Inhoffen W; Tatar O
    Retina; 2006; 26(6):693-7. PubMed ID: 16829815
    [No Abstract]   [Full Text] [Related]  

  • 53. Photodynamic therapy with verteporfin for choroidal neovascularization complicating angioid streaks.
    Karadimas P; Bouzas EA
    Ophthalmic Surg Lasers Imaging; 2004; 35(1):78-80. PubMed ID: 14750772
    [No Abstract]   [Full Text] [Related]  

  • 54. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
    Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y
    Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accidental pregnancy exposure to verteporfin: obstetrical and neonatal outcomes: a case report.
    Rodrigues M; Meira D; Batista S; Carrilho MM
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):236-7. PubMed ID: 19432621
    [No Abstract]   [Full Text] [Related]  

  • 56. Verteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditis.
    Mauget-Faÿsse M; Mimoun G; Ruiz-Moreno JM; Quaranta-El Maftouhi M; De Laey JJ; Postelmans L; Soubrane G; Defauchy M; Leys A
    Retina; 2006 Apr; 26(4):396-403. PubMed ID: 16603957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD.
    Goldstein M; Heilweil G; Barak A; Loewenstein A
    Eye (Lond); 2005 Dec; 19(12):1315-24. PubMed ID: 15803179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
    Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I
    Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute severe visual decrease after photodynamic therapy with verteporfin: spectral-domain OCT features.
    Keane PA; Aghaian E; Ouyang Y; Chong LP; Sadda SR
    Ophthalmic Surg Lasers Imaging; 2010; 41 Suppl():S85-8. PubMed ID: 21117609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Photodynamic therapy.
    Kotoula MG; Tsironi EE; Karabatsas CH; Chatzoulis DZ
    Retina; 2005 Jan; 25(1):102-3. PubMed ID: 15655455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.